CVS Caremark (CVS) Tops Q3 EPS by 3c; Narrows Outlook
Tweet Send to a Friend
CVS Caremark (NYSE: CVS) reported Q3 EPS of $1.05, $0.03 better than the analyst estimate of $1.02. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
